QOSHE - Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro - Madison Muller
menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro

13 0
01.12.2023
Shares in the COVID vaccine maker are set to plumb five-year lows after Pfizer dropped development due to the drug's side effects that included nausea and vomiting.

© Fortune


Get it on Google Play